AlphaStocks
1.6
Avoid

Tandem Diabetes Care Inc (TNDM)

As of Sep 19, 2026, Tandem Diabetes Care Inc (TNDM) scores 1.6/10 on AlphaStocks' five-model composite, #168 of 168 Health Care stocks.

Health Care / Health Care Equipment

S&P SmallCap 600

$16.86

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

Data as of Sep 19, 2026

#168out of 168 in Health Care

Is TANDEM DIABETES CARE INC a Good Investment in 2026?

TANDEM DIABETES CARE INC (TNDM) scores 1.6 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating TANDEM DIABETES CARE INC as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -14.9% · ROC -41%. TANDEM DIABETES CARE INC ranks #168 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-14.7Market Cap1B

Valuation

Currently unprofitable — fair value estimate not available.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -14.9% · ROC -41%

Frequently Asked Questions

Is TANDEM DIABETES CARE INC (TNDM) a good investment?
As of Sep 19, 2026, Tandem Diabetes Care Inc (TNDM) scores 1.6/10 on AlphaStocks' five-model composite, #168 of 168 Health Care stocks. That score is below average, suggesting caution. Currently unprofitable — fair value estimate not available.
What is TANDEM DIABETES CARE INC's Piotroski F-Score?
TANDEM DIABETES CARE INC's Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is TNDM overvalued or undervalued?
A precise fair value estimate is not available for TNDM. Currently unprofitable — fair value estimate not available.
How does TNDM compare to other Health Care stocks?
TANDEM DIABETES CARE INC ranks #168 out of 168 stocks in the Health Care sector, placing it in the top 100% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about TNDM?
AlphaStocks evaluates TNDM using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 1.6/10.

Similar Stocks

Compare TNDM with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer